3-iodobenzylguanidine has been researched along with Malignant Carcinoid Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Boot, H; Hoefnagel, CA; Taal, BG; Valdes Olmos, RA | 1 |
| Boot, H; Hoefnagel, CA; Taal, BG; Valdés Olmos, RA | 1 |
| Currie, C; Davies, JS; Green, J | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Radionuclide Imaging; Somatostatin; Tomography, X-Ray Computed | 1996 |
2 other study(ies) available for 3-iodobenzylguanidine and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoid Tumor; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Malignant Carcinoid Syndrome; Middle Aged; Palliative Care; Radionuclide Imaging; Tomography, X-Ray Computed | 1996 |
Carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Malignant Carcinoid Syndrome | 1997 |